medivation inc (MDVN:NASDAQ GS)
Marc A. Shuman M.D.
Member of Scientific & Clinical Advisory Board, Medivation, Inc.
|Age||Total Calculated Compensation||This person is connected to 13 board members in 1 different organizations across 1 different industries.|
See Board Relationships
Marc A. Shuman M.D. serves as a Member of Scientific and Clinical Advisory Board of Medivation, Inc. Dr. Shuman is Professor of Medicine at the University of California, San Francisco, and Chief of Hematology and Director of the Prostate Cancer Program at the UCSF Comprehensive Cancer Center. Dr. Shuman also serves as Clinical Director of the California Institute for Quantitative Biomedical Research. Dr. Shuman is a member of the American Society ...
525 Market StreetPhone: 415-543-3470
San Francisco, California 94105
Board Members Memberships*There is no Board Members Memberships data available.
University of Wisconsin - Madison
The University of Pennsylvania
Thomas Jefferson University School Of Medicine
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Harvey J. Berger M.D.||Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee|
Ariad Pharmaceuticals Inc.
|Clay B. Siegall Ph.D.||Co-Founder, Chairman, Chief Executive Officer and President|
Seattle Genetics, Inc.
|Shailesh Ayyangar B.V.Fc & A.H., P.G.D.M.||Managing Director, Vice President of South Asia- Global Operations, Executive Director and Member of Audit Committee|
Sanofi India Limited
|Aijaz Tobaccowalla||Managing Director, Director, Member of Nomination and Remuneration Committee and Member of Board Administrative Committee|
|Michael L. Babich||Chief Executive Officer, President and Director|
INSYS Therapeutics, Inc.
|$1.0M||Compensation as of Fiscal Year 2013.|